These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 6138953)

  • 41. Nutritional therapy can reduce the burden of depression management in low income countries: A review.
    Ekong MB; Iniodu CF
    IBRO Neurosci Rep; 2021 Dec; 11():15-28. PubMed ID: 34939062
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Iron-deficiency and dopaminergic treatment effects on RLS-Like behaviors of an animal model with the brain iron deficiency pattern of the restless legs syndrome.
    Allen RP; Earley CJ; Jones BC; Unger EL
    Sleep Med; 2020 Jul; 71():141-148. PubMed ID: 32094092
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Guts, Germs, and Iron: A Systematic Review on Iron Supplementation, Iron Fortification, and Diarrhea in Children Aged 4-59 Months.
    Ghanchi A; James PT; Cerami C
    Curr Dev Nutr; 2019 Mar; 3(3):nzz005. PubMed ID: 30891538
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Restless Legs Syndrome and Parkinson Disease: A Causal Relationship Between the Two Disorders?
    Ferini-Strambi L; Carli G; Casoni F; Galbiati A
    Front Neurol; 2018; 9():551. PubMed ID: 30087647
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peripheral iron levels in children with attention-deficit hyperactivity disorder: a systematic review and meta-analysis.
    Tseng PT; Cheng YS; Yen CF; Chen YW; Stubbs B; Whiteley P; Carvalho AF; Li DJ; Chen TY; Yang WC; Tang CH; Chu CS; Yang WC; Liang HY; Wu CK; Lin PY
    Sci Rep; 2018 Jan; 8(1):788. PubMed ID: 29335588
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Restless legs syndrome and its associated risk factors in Parkinson's disease.
    Azmin S; Khairul Anuar AM; Nafisah WY; Tan HJ; Raymond AA; Hanita O; Shah SA; Norlinah MI
    Parkinsons Dis; 2013; 2013():535613. PubMed ID: 24455416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Up-regulation of striatal adenosine A(2A) receptors with iron deficiency in rats: effects on locomotion and cortico-striatal neurotransmission.
    Quiroz C; Pearson V; Gulyani S; Allen R; Earley C; Ferré S
    Exp Neurol; 2010 Jul; 224(1):292-8. PubMed ID: 20385128
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sleep disturbances and serum ferritin levels in children with attention-deficit/hyperactivity disorder.
    Cortese S; Konofal E; Bernardina BD; Mouren MC; Lecendreux M
    Eur Child Adolesc Psychiatry; 2009 Jul; 18(7):393-9. PubMed ID: 19205783
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dopamine D2 receptor expression is altered by changes in cellular iron levels in PC12 cells and rat brain tissue.
    Unger EL; Wiesinger JA; Hao L; Beard JL
    J Nutr; 2008 Dec; 138(12):2487-94. PubMed ID: 19022977
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Brain sites of movement disorder: genetic and environmental agents in neurodevelopmental perturbations.
    Palomo T; Beninger RJ; Kostrzewa RM; Archer T
    Neurotox Res; 2003; 5(1-2):1-26. PubMed ID: 12832221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulation of dopamine receptor in the striatum by iron: behavioral and biochemical correlates.
    Youdim MB; Ashkenazi R; Ben-Shachar D; Yehuda S
    Adv Neurol; 1984; 40():159-70. PubMed ID: 6695592
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Minimal brain damage induced by early iron deficiency: modified dopaminergic neurotransmission.
    Youdim MB; Ben-Shachar D
    Isr J Med Sci; 1987; 23(1-2):19-25. PubMed ID: 3032848
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Electroconvulsive shock and neurotransmitter receptors: implications for mechanism of action and adverse effects of electroconvulsive therapy.
    Lerer B
    Biol Psychiatry; 1984 Mar; 19(3):361-83. PubMed ID: 6144329
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cholecystokinin2 receptor-deficient mice display altered function of brain dopaminergic system.
    Kõks S; Volke V; Veraksits A; Rünkorg K; Sillat T; Abramov U; Bourin M; Huotari M; Männistö PT; Matsui T; Vasar E
    Psychopharmacology (Berl); 2001 Nov; 158(2):198-204. PubMed ID: 11702094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brain iron and dopamine receptor function.
    Youdim MB; Ben-Shachar D; Ashkenazi R; Yehuda S
    Adv Biochem Psychopharmacol; 1983; 37():309-21. PubMed ID: 6138953
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.